Okaya, Japan

Hironobu Fubasami

This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hironobu Fubasami. Retrieved from https://idiyas.com/inventor/hironobu-fubasami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hironobu Fubasami: Innovator in Medicinal Chemistry

Introduction

Hironobu Fubasami is a notable inventor based in Okaya, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that serve as intermediates in pharmaceutical applications.

Latest Patents

Fubasami holds a patent for a compound described as (6,7)-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro. This invention relates to novel compounds that are useful as intermediates in the preparation of quinoline carboxylic acid medicaments. His innovative work in this area has the potential to impact the development of new therapeutic agents.

Career Highlights

Hironobu Fubasami is associated with Kyorin Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development efforts. His expertise in medicinal chemistry has contributed to the company's mission of creating effective pharmaceutical solutions.

Collaborations

Fubasami has collaborated with notable colleagues, including Naomi Takagi and Hiroshi Matsukubo. These partnerships have fostered a collaborative environment that enhances the innovation process within the company.

Conclusion

Hironobu Fubasami's contributions to medicinal chemistry and his innovative patent work exemplify the importance of research in developing new medical treatments. His ongoing efforts continue to shape the future of pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…